The Los Angeles (LA) Times reports on the 25th anniversary of the Compassionate Use Act of 1996, and asks: Is it high time for the Feds to legalize weed? The LA Times spoke with Dr. Igor Grant, Director of the Center for Medicinal Cannabis Research, as well as Dr. Doris Trauner, the Principal Investigator of the study on autism and cannabidiol (CBD). Click here to see the video or here for the online version.
CMCR research was featured on PBS NOVA on September 29, 2021. As part of this update to the public on medicinal and recreational cannabis, NOVA reached out to Professor Doris Trauner, lead investigator in CMCR’s study on the possible efficacy of cannabidiol (CBD) in the management of symptoms of severe autism. Click here to view the program.
Findings show that cannabis lowers intraocular pressure significantly in adult healthy subjects
Elisabeth Frausto, La Jolla Light, June 25, 2021
Dr. Doris Trauner is leading a CMCR clinical trial studying the effects of CBD on symptoms of severe autism in children. The study is currently enrolling participants and hopes to determine whether CBD reduces the problem behaviors seen in children with severe autism. Click here for a description of the study and link to a survey for those interested in participating.
Read the full La Jolla Light article here
Findings show that daily cannabis use was associated with lower inflammation in the central nervous system in people with HIV
Page 12 of 22